These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan. Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Furumoto A; Kobayashi S; Sato A; Nagatake T J Hosp Infect; 2001 Apr; 47(4):294-300. PubMed ID: 11289773 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA; Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128 [TBL] [Abstract][Full Text] [Related]
4. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. Fawley WN; Parnell P; Hall J; Wilcox MH J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029 [TBL] [Abstract][Full Text] [Related]
5. Mupirocin resistance among Iranian isolates of Staphylococcus aureus. Saderi H; Owlia P; Habibi M Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185 [TBL] [Abstract][Full Text] [Related]
6. [Occurrence of high-level mupirocin resistant coagulase-negative staphylococci in hospitals and their characterization]. Wiśniewska K; Michnowska-Swincow E; Galiński J Med Dosw Mikrobiol; 2004; 56(3):217-23. PubMed ID: 15773497 [TBL] [Abstract][Full Text] [Related]
7. The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. Hurdle JG; O'Neill AJ; Chopra I J Antimicrob Chemother; 2004 Jan; 53(1):102-4. PubMed ID: 14657089 [TBL] [Abstract][Full Text] [Related]
8. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. Petinaki E; Spiliopoulou I; Kontos F; Maniati M; Bersos Z; Stakias N; Malamou-Lada H; Koutsia-Carouzou Ch; Maniatis AN J Antimicrob Chemother; 2004 Jan; 53(1):105-8. PubMed ID: 14657085 [TBL] [Abstract][Full Text] [Related]
9. Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R; Samantaray JC Diagn Microbiol Infect Dis; 2007 May; 58(1):125-7. PubMed ID: 17240103 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus. Sato M; Tanaka H; Yamaguchi R; Kato K; Etoh H Int J Antimicrob Agents; 2004 Sep; 24(3):241-6. PubMed ID: 15325427 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus. Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413 [TBL] [Abstract][Full Text] [Related]
14. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986 [TBL] [Abstract][Full Text] [Related]
15. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Orrett FA Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397 [TBL] [Abstract][Full Text] [Related]
16. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions. Hill RL; Casewell MW J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. LaPlante KL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452 [TBL] [Abstract][Full Text] [Related]
18. A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance. Udo EE; Al-Sweih N; Noronha BC J Antimicrob Chemother; 2003 May; 51(5):1283-6. PubMed ID: 12668579 [TBL] [Abstract][Full Text] [Related]
19. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881 [TBL] [Abstract][Full Text] [Related]
20. Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro. Thomas DG; Wilson JM; Day MJ; Russell AD J Appl Microbiol; 1999 Apr; 86(4):715-22. PubMed ID: 10212417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]